Revolution Medicines expects top-line data from the Phase III RASolute 302 trial in second-line PDAC in 1H 2026; the study is designed as an OS event-driven program and is powered primarily for ...

SPIDER-MAN MUST SAVE NORMAN OSBORN… FROM IRON MAN?! Tony Stark and Norman Osborn have history. They've known each other longer than you might know. And when the Iron Patriot armor is stolen, all signs ...

The first thing you hear is not a quip, or even a punch being thrown. It's Nicolas Cage, voice low and frayed, muttering a line that sounds like someone has taken a sledgehammer to one of pop ...

Chris joined CarBuzz in June 2025. He's held positions at Ford and Motor1, and contributed to Autoblog, Car Throttle, Auto Trader, and many other motoring outlets during his 28-year career. Chris ...

Joel was previously an editor at Autoblog for nearly a decade, covering cars from humble economy hatchbacks to high-end sports cars. He has extensive driving experience with plenty of track time, and ...

A Ferrari F430 Spider that once struggled to stand out in the collector market has found new life — and a significantly higher value — after undergoing a manual transmission conversion. Originally ...

Patterns of decision making about cancer clinical trial participation among the online cancer treatment community: A collaboration between SWOG and NexCura. This is an ASCO Meeting Abstract from the ...

A randomized, multicenter, phase 3 study of nivolumab vs sorafenib as first-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): CheckMate-459. This is an ASCO Meeting ...

It is estimated that by 2030, 1 in 6 people worldwide will be over 60. Meanwhile, 1 in ten children in the UK are now expected to live beyond 100.